Skip to content
Open access

Malignant B-cell States Orchestrate Spatially Organized Immune Ecosystems in B-cell Lymphomas

Aug 2026 · Research Square · 0 citations
Medicine

TL;DR

Findings establish malignant differentiation state as a causal determinant of immune architecture across GC-derived lymphomas and identify lineage-directed immune reprogramming as a potential therapeutic strategy.

Abstract

Germinal center (GC)-derived lymphomas arise within a specialized immune ecosystem, yet whether malignant cells direct its remodeling remains unclear. Integrating genomic, transcriptomic, spatial, and functional analyses across follicular lymphoma and diffuse large B-cell lymphoma, we define a developmental framework linking malignant B-cell differentiation state to tumor microenvironment (TME) organization. Rather than segregating by histology, lymphomas align along a shared differentiation continuum in which proliferative dark zone (DZ) states associate with immune-depleted TMEs, whereas post-GC/memory B-cell (MBC) states drive inflamed but immunosuppressed TMEs. Spatial profiling reveals collapse of GC architecture and emergence of suppressive myeloid niches along this trajectory. Single-cell lineage reconstruction uncovers a DZ-to-MBC developmental axis underlying lymphoma evolution. Genetic reprogramming in vivo demonstrates that malignant differentiation state is sufficient to instruct TME remodeling. Collectively, these findings establish malignant differentiation state as a causal determinant of immune architecture across GC-derived lymphomas and identify lineage-directed immune reprogramming as a potential therapeutic strategy.

Read PDF

Similar papers

Review Open access Jul 2026

Formation and remodeling of immunological niches in solid tumors: organ-specific architectures, inflammatory parallels, and therapeutic reprogramming

It is argued that tumor immunological niches may serve as meso-level analytical units linking spatial organization, organ context, evidence strength, inflammatory parallels, and therapeutic vulnerability when their evidentiary status is explicitly defined.

Zhuo Zhang, Yunyi Dong, Jin-Chao Li et al. · 0 citations
Jul 2026

Disease-associated microglia adopt stage-specific phenotypes that regulate T cell fate and immunity in glioma.

This work integrated single-cell profiling and spatial transcriptomics of glioma-associated microglia in the GL261 model to identify distinct microglial states that aligned with tumor architecture and highlighted microglial state transitions as a stage-specific layer of immune regulation in glioma that shapes T cell fa...

Jia-Wen Qian, Chen Wang, Yi Zhang et al. · 0 citations
Open access Aug 2026

Tumor-infiltrating B cells evolve towards interferon-rich trajectories aligned with immunotherapy in melanoma

Melanoma-infiltrating B cells follow class-switched differentiation trajectories culminating in IFN signaling, atypical antibody expressing states that persist or emerge after immunotherapy, aligning dynamic B cell evolution and atypical lineage traits with immunotherapy.

K. Stoker, R. Laddach, Lucy Booth et al. · 0 citations
Open access Aug 2026

Spatial remodeling of the thymic stroma with age disrupts niches for T cell selection and tolerance

A spatially resolved multi-omic atlas of the aging mouse thymus is generated and reframe thymic involution as spatial stromal reorganization that links stromal remodeling to impaired thymopoiesis, central tolerance, and immune aging.

Andreas Tarcevski, Fatima Dhalla, Joshua W. Moore et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.